|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
After hours 19:25:08 | |||
| 11.26 USD | -12.17% |
|
11.20 | -0.58% |
Company Valuation: Novavax, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 10,817 | 883.9 | 570.2 | 1,288 | 1,092 | 1,856 | - | - |
| Change | - | -91.83% | -35.49% | 125.87% | -15.21% | 70.01% | - | - |
| Enterprise Value (EV) 1 | 9,756 | -228.1 | 169.7 | 534.5 | 1,096 | 2,075 | 2,160 | 1,856 |
| Change | - | -102.34% | 174.39% | 214.93% | 104.99% | 89.44% | 4.06% | -14.04% |
| P/E | -6.1x | -1.22x | -0.89x | -6.54x | 2.6x | -21.7x | -136x | 40.1x |
| PBR | -30.9x | -1.38x | -0.93x | -2.07x | -8.55x | -3.21x | -3.07x | - |
| PEG | - | 0x | 0x | 0.1x | -0x | 0x | 1.6x | -0x |
| Capitalization / Revenue | 9.44x | 0.45x | 0.58x | 1.89x | 0.97x | 4.77x | 6.4x | 6.97x |
| EV / Revenue | 8.51x | -0.12x | 0.17x | 0.78x | 0.98x | 5.33x | 7.44x | 6.97x |
| EV / EBITDA | - | 0.37x | -0.32x | -2.67x | 2.28x | -39x | -62.9x | -22.3x |
| EV / EBIT | -5.78x | 0.35x | -0.3x | -2.15x | 2.42x | -23.2x | -197x | 36.9x |
| EV / FCF | 36.8x | 0.45x | -0.22x | -5.33x | -4.38x | -9.14x | -46x | 15.5x |
| FCF Yield | 2.72% | 221% | -452% | -18.8% | -22.8% | -10.9% | -2.18% | 6.44% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.44 | -8.42 | -5.41 | -1.23 | 2.58 | -0.5196 | -0.083 | 0.2804 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,146 | 1,982 | 983.7 | 682.2 | 1,123 | 389.3 | 290.3 | 266.5 |
| EBITDA 1 | - | -615.7 | -525.3 | -200.4 | 480.4 | -53.18 | -34.33 | -83.23 |
| EBIT 1 | -1,687 | -644.7 | -566.5 | -248.9 | 452.8 | -89.27 | -10.95 | 50.27 |
| Net income 1 | -1,744 | -657.9 | -545.1 | -187.5 | 440.3 | -89.44 | -14.39 | 44.2 |
| Net Debt 1 | -1,061 | -1,112 | -400.5 | -753.4 | 3.579 | 219 | 303.2 | - |
| Reference price 2 | 143.07 | 10.28 | 4.80 | 8.04 | 6.72 | 11.26 | 11.26 | 11.26 |
| Nbr of stocks (in thousands) | 75,608 | 85,979 | 118,790 | 160,185 | 162,499 | 164,946 | - | - |
| Announcement Date | 2/28/22 | 2/28/23 | 2/28/24 | 2/27/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.67x | 5.99x | -43.88x | -.--% | 2.11B | |
| 20.07x | 7.14x | 14.31x | 1.48% | 68.98B | |
| 28.61x | 7.85x | 24.63x | 0.05% | 53.15B | |
| 35.29x | 6.26x | 18.73x | 0.92% | 50.83B | |
| 34.21x | 3.36x | 14.49x | -.--% | 44.61B | |
| -19.62x | 197.94x | -20.83x | -.--% | 40.57B | |
| 49.56x | 5.68x | 31.19x | -.--% | 42.53B | |
| 27.19x | 7.72x | 19.99x | 0.39% | 30.95B | |
| 29.37x | 6.23x | 16.17x | -.--% | 25.44B | |
| -13.66x | 5.14x | -6.23x | -.--% | 22.66B | |
| Average | 16.63x | 25.33x | 6.86x | 0.28% | 38.18B | |
| Weighted average by Cap. | 22.95x | 26.65x | 13.55x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- NVAX Stock
- Valuation Novavax, Inc.
Select your edition
All financial news and data tailored to specific country editions
